Sign in

CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company

Nuvation Bio Inc.

Sign in to watch
Ticker
NUVB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850862255
Phone
332-208-6102
Business address
1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
Former names
Panacea Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$709,240
in 1 filing, $709K under 10b5-1 plans

Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hattersley Gary −$709K CHIEF SCIENTIFIC OFFICER sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-10 Hattersley Gary Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +398,935 398,935
2021-02-10 Yurasov Sergey Chief Medical Officer Grant or award · Stock Option (Right to Buy) +398,935 398,935
2021-02-10 Yurasov Sergey Chief Medical Officer Grant or award · Stock Option (Right to Buy) +398,935 398,935
2021-02-10 Fox Jennifer A. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +398,935 398,935
2021-02-10 Fox Jennifer A. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +558,506 558,506
2021-02-10 Hung David President and CEO Grant or award +56,645,012 56,645,012
2021-02-10 Hung David President and CEO Grant or award +2,000,000 $10.00 $20.0M 58,645,012
2021-02-10 Hung David President and CEO Grant or award · Class B Common Stock +1,000,000 1,000,000
2020-07-06 EcoR1 Panacea Holdings, LLC Director Purchase +390,000 $10.00 $3.9M 390,000
2020-02-10 VERNON W ANTHONY Director Grant or award +254,100 254,100
2020-02-10 VERNON W ANTHONY Director Grant or award +50,000 $10.00 $500K 304,100

Page 15 of 15 · 291 trades